US Patent Issued to Eagle Pharmaceuticals on July 29 for "Fulvestrant formulations and methods of their use" (New Jersey, California Inventors)

ALEXANDRIA, Va., July 30 -- United States Patent no. 12,370,199, issued on July 29, was assigned to Eagle Pharmaceuticals Inc. (Woodcliff Lake, N.J.).

"Fulvestrant formulations and methods of their use" was invented by Feng-Jing Chen (Irvine, Calif.), Steven L. Krill (Midland Park, N.J.) and Rama Abu Shmeis (Branchburg, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure is directed to fulvestrant formulations including suspensions of fulvestrant particles suitable for injection. The formulations can comprise fulvestrant particles having an LD Dv(10) less than about 3 microns, for example, between about 1 micron to about 3 microns, an LD Dv(50) less than about 35 microns, for example, between ...